Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

We need safe, affordable drugs to fight coronaviruses effectively.

Allopregnanolone changes gene expression in glioblastoma cells.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

Key pathways like WNT, EGF, FGF, SHH, and BMP regulate poultry feather growth, with BMP inhibiting it.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

A new lab-grown lung model helps study adenoviruses and test antiviral drugs.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

Genetically modified cells can regenerate skin and hair in rats.

Gene therapy shows promise for treating hair loss by targeting hair follicles.

No link found between Coxsackie viruses and pemphigus.

Engineered extracellular vesicles could improve CRISPR/Cas delivery, making gene editing safer and more effective.

This method is effective for needle-free HIV-1 vaccination by activating immune responses in the skin.

The method effectively delivers vaccines through the skin without needles.

Biomaterials can improve non-viral gene delivery by enhancing DNA uptake and reducing toxicity.

A new delivery system makes Curcumin more effective and safer against viruses.

Effective delivery of gene editors is crucial for safe and successful gene editing in healthcare and agriculture.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Engineered vesicles with EGF mRNA improve skin wound healing and reduce scarring.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Intranasal delivery of gene therapy shows promise for treating ischemic stroke.

Ethosomes are effective, safe carriers for delivering drugs through the skin.

Nonionic liposomes are the best for delivering genes to skin cells.

Non-viral delivery systems and stimuli-responsive nanoformulations can improve CRISPR-Cas9 gene therapy.